News
CBIOS leads FCT funded project in atopic dermatitis
The pentagonal coalition of ceramides, insect oil, ionic liquids, nanotechnology, and glucocorticoids in a multifunctional nanoformulation will allow overcoming existing therapeutic limitations of atopic dermatitis.
BIOMATNANO4AD will be led by a multidisciplinary team from CBIOS partnered with a biotech company (EntoGreen), LAQV and Vienna University. This exploratory project was funded under the IC&DT call from FCT.